Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility
| Brand name | LIDOCAINE HYDROCHLORIDE |
| Generic name | LIDOCAINE HYDROCHLORIDE |
| Active ingredient(s) | LIDOCAINE HYDROCHLORIDE |
| Distributed by / for | McKesson Corporation, dba Sky Packaging |
| NDC | 73293-0001-1 |
| Full product label | Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by: Huons Co, Ltd, Chungcheongbuk-do, Korea NDC 73293-0001-1 (vial), NDC 73293-0001-2 (10 count carton); Distributed by: McKesson Corporation, dba Sky Packaging, NDC 63739-170-13 (vials), NDC 63739-170-24 (10 count cartons) and NDC 63739-170-27 (25 count cartons); Distributed by: Brookefield Pharmaceuticals, LLC, Brookefield, WI, Manufactured by: Huons Co., Ltd., 100 Bio valley-ro, Jecheon-si, Chungchengbuk-do, Korea, NDC 71351-021-05 (vials), NDC 71351-021-10 (10 count cartons), NDC 71351-021-25 (25 count cartons); Distributed by Novagenix Labs LLC, Morrisville, NC NDC 84769-0001-1 (vials), NDC 84769-0001-2 (10 count carton) |
| Recalling firm | Huons Co., Ltd. |
| Distribution | USA Nationwide. |
| Quantity | 33,599,925 ampules and 23658125 vials |
| Recall initiated | 2026-04-02 |
| Report date | 2026-04-22 |
| Recall completed | — |
| Recall number | D-0529-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Jecheon N/A Korea (the Republic of) |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗